U.S. FDA Issues Vision Loss Warning for Popular GLP-1 Medications

The U.S. Food and Drug Administration has issued a new warning regarding rare instances of vision loss associated with GLP-1 medications, including drugs like Ozempic. This advisory impacts popular drugs prescribed for weight management and diabetes, highlighting potential adverse effects for patients and healthcare providers.